Scheunemann Johanna F, Risch Frederic, Reichwald Julia J, Lenz Benjamin, Neumann Anna-Lena, Garbe Stephan, Frohberger Stefan J, Koschel Marianne, Ajendra Jesuthas, Rothe Maximilian, Latz Eicke, Coch Christoph, Hartmann Gunther, Schumak Beatrix, Hoerauf Achim, Hübner Marc P
Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, 53127 Bonn, Germany.
Clinic for Radiotherapy and Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Vaccines (Basel). 2023 May 10;11(5):966. doi: 10.3390/vaccines11050966.
More than two-hundred-million people are infected with filariae worldwide. However, there is no vaccine available that confers long-lasting protection against filarial infections. Previous studies indicated that vaccination with irradiated infective L3 larvae reduces the worm load. This present study investigated whether the additional activation of cytosolic nucleic acid receptors as an adjuvant improves the efficacy of vaccination with irradiated L3 larvae of the rodent filaria with the aim of identifying novel vaccination strategies for filarial infections. Subcutaneous injection of irradiated L3 larvae in combination with poly(I:C) or 3pRNA resulted in neutrophil recruitment to the skin, accompanied by higher IP-10/CXCL10 and IFN-β RNA levels. To investigate the impact on parasite clearance, BALB/c mice received three subcutaneous injections in 2-week intervals with irradiated L3 larvae in combination with poly(I:C) or 3pRNA prior to the challenge infection. Vaccination with irradiated L3 larvae in combination with poly(I:C) or 3pRNA led to a markedly greater reduction in adult-worm counts by 73% and 57%, respectively, compared to the immunization with irradiated L3 larvae alone (45%). In conclusion, activation of nucleic acid-sensing immune receptors boosts the protective immune response against and nucleic acid-receptor agonists as vaccine adjuvants represent a promising novel strategy to improve the efficacy of vaccines against filariae and potentially other helminths.
全球有超过两亿人感染丝虫。然而,目前尚无能够提供针对丝虫感染的长效保护的疫苗。先前的研究表明,用经辐照的感染性L3幼虫进行疫苗接种可减少虫负荷。本研究调查了作为佐剂额外激活胞质核酸受体是否能提高用啮齿动物丝虫的经辐照L3幼虫进行疫苗接种的效果,目的是确定针对丝虫感染的新型疫苗接种策略。皮下注射经辐照的L3幼虫与聚肌胞苷酸(poly(I:C))或3pRNA结合,导致中性粒细胞募集到皮肤,同时伴有更高的IP-10/CXCL10和IFN-β RNA水平。为了研究对寄生虫清除的影响,BALB/c小鼠在攻击感染前每隔2周接受三次皮下注射经辐照的L3幼虫与聚肌胞苷酸或3pRNA的组合。与单独用经辐照的L3幼虫免疫(45%)相比,用经辐照的L3幼虫与聚肌胞苷酸或3pRNA组合进行疫苗接种分别使成虫数量显著减少73%和57%。总之,激活核酸感应免疫受体可增强针对丝虫的保护性免疫反应,并且核酸受体激动剂作为疫苗佐剂代表了一种有前景的新型策略,可提高针对丝虫以及潜在其他蠕虫的疫苗效果。